VERONA PHARMA PLC

VRNA

Exchange NGM, Currency in USD

Loading price...

Overview

Previous Close104.90

Open104.92

Ask105.00

Bid104.78

Day's Range104.85 - 105.06

52 Week Range18.51 - 105.30

PE Ratio(TTM)--

Market Cap8.91B

Volume2.52M

Avg. Volume3.37M

Profit/Loss

PARTICULARS
No results to display

Company Profile

Sector: Healthcare

Industry: Biotechnology

HQ Location: London, United Kingdom

Website: https://www.veronapharma.com

President, CEO & Executive Director: Dr. David S. Zaccardelli Pharm.D.

Employees: 209

About Company:

Verona Pharma plc, a biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company offers Ohtuvayre, a dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that combines bronchodilator and non-steroidal anti-inflammatory effects for the maintenance treatment of chronic obstructive pulmonary disease, as well as cystic fibrosis and asthma. Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom.